{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T10:34:29Z","timestamp":1782038069394,"version":"3.54.5"},"reference-count":53,"publisher":"Medical Association of Nippon Medical School","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2024,4,25]]},"DOI":"10.1272\/jnms.jnms.2024_91-215","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T22:12:10Z","timestamp":1716243130000},"page":"140-145","source":"Crossref","is-referenced-by-count":5,"title":["&lt;i&gt;RNF213&lt;\/i&gt;-Related Vasculopathy: Various Systemic Vascular Diseases Involving &lt;i&gt;RNF213&lt;\/i&gt; Gene Mutations: Review"],"prefix":"10.1272","volume":"91","author":[{"given":"Yasuo","family":"Murai","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Matano","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Nounaka","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Ishisaka","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Musashi Kosugi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Shirokane","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Koketsu","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Nakae","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ishisaka E, Watanabe A, Murai Y, et al. Role of RNF213 polymorphism in defining quasi-moyamoya disease and definitive moyamoya disease. Neurosurg Focus. 2021;51 (3):E2. doi: 10.3171\/2021.5.FOCUS21182","DOI":"10.3171\/2021.5.FOCUS21182"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6 (7):e22542. doi: 10.1371\/journal.pone.0022542","DOI":"10.1371\/journal.pone.0022542"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Park YS, An HJ, Kim JO, et al. The role of RNF213 4810G&gt;A and 4950G&gt;A variants in patients with moyamoya disease in Korea. Int J Mol Sci. 2017;18 (11):2477. doi: 10.3390\/IJMS18112477","DOI":"10.3390\/ijms18112477"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Liu W, Hashikata H, Inoue K, et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med. 2010;15 (2):94-104. doi: 10.1007\/S12199-009-0116-7","DOI":"10.1007\/s12199-009-0116-7"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Hiraide T, Suzuki H, Momoi M, et al. RNF213-associated vascular disease: a concept unifying various vasculopathies. Life (Basel). 2022;12 (4):555. doi: 10.3390\/LIFE12040555","DOI":"10.3390\/life12040555"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Morimoto T, Mineharu Y, Ono K, et al. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease. PLoS One. 2017;12 (4):e0175649. doi: 10.1371\/journal.pone.0175649","DOI":"10.1371\/journal.pone.0175649"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Murai Y, Ishisaka E, Watanabe A, et al. Rnf213 c.14576g&gt;a is associated with intracranial internal carotid artery saccular aneurysms. Genes (Basel). 2021;12 (10):1468. doi: 10.3390\/genes12101468","DOI":"10.3390\/genes12101468"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70 (24 Pt 2):2357-63. doi: 10.1212\/01.wnl.0000291012.49986.f9","DOI":"10.1212\/01.wnl.0000291012.49986.f9"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56 (1):34-40. doi: 10.1038\/jhg.2010.132","DOI":"10.1038\/jhg.2010.132"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Miyawaki S, Imai H, Takayanagi S, Mukasa A, Nakatomi H, Saito N. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis\/occlusion. Stroke. 2012;43 (12):3371-4. doi: 10.1161\/STROKEAHA.112.663864","DOI":"10.1161\/STROKEAHA.112.663864"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Miyawaki S, Imai H, Shimizu M, et al. Genetic variant RNF213 c.14576G&gt;A in various phenotypes of intracranial major artery stenosis\/occlusion. Stroke. 2013;44 (10):2894-7. doi: 10.1161\/STROKEAHA.113.002477","DOI":"10.1161\/STROKEAHA.113.002477"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Graf J, Schwitalla JC, Albrecht P, et al. Misdiagnoses and delay of diagnoses in moyamoya angiopathy-a large Caucasian case series. J Neurol. 2019;266 (5):1153-9. doi: 10.1007\/s00415-019-09245-9","DOI":"10.1007\/s00415-019-09245-9"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Grami N, Chong M, Lali R, et al. Global assessment of Mendelian stroke genetic prevalence in 101 635 individuals from 7 ethnic groups. Stroke. 2020;1290-3. doi: 10.1161\/STROKEAHA.119.028840","DOI":"10.1161\/STROKEAHA.119.028840"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Zhou H, Jing J, Pu Y, et al. Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack. Stroke Vasc Neurol. 2023;8 (6):503-10. doi: 10.1136\/svn-2022-002276","DOI":"10.1136\/svn-2022-002276"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Wu Z, Jiang H, Zhang L, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One. 2012;7 (10):e48179. doi: 10.1371\/journal.pone.0048179","DOI":"10.1371\/journal.pone.0048179"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo). 2012;52 (5):299-303. doi: 10.2176\/nmc.52.299","DOI":"10.2176\/nmc.52.299"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Wang X, Zhang Z, Liu W, et al. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of moyamoya disease in Han Chinese human subjects. Gene. 2013;526 (2):437-42. doi: 10.1016\/j.gene.2013.05.083","DOI":"10.1016\/j.gene.2013.05.083"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Jeon JP, Hong EP, Ha EJ, et al. Genome-wide association study identifies novel susceptibilities to adult moyamoya disease. J Hum Genet. 2023;68 (10):713-20. doi: 10.1038\/S10038-023-01167-9","DOI":"10.1038\/s10038-023-01167-9"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Guey S, Kraemer M, Herve D, et al. Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet. 2017;25 (8):995-1003. doi: 10.1038\/ejhg.2017.92","DOI":"10.1038\/ejhg.2017.92"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Cecchi AC, Guo D, Ren Z, et al. RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke. 2014;45 (11):3200-7. doi: 10.1161\/STROKEAHA.114.006244","DOI":"10.1161\/STROKEAHA.114.006244"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Okazaki S, Morimoto T, Kamatani Y, et al. Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis. Circulation. 2019;139 (2):295-8. doi: 10.1161\/CIRCULATIONAHA.118.038439","DOI":"10.1161\/CIRCULATIONAHA.118.038439"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Murai Y, Ishisaka E, Watanabe A, et al. Ring finger protein 213 c.14576G&gt;A mutation is not involved in internal carotid artery and middle cerebral artery dysplasia. Sci Rep. 2021;11 (1):22163. doi: 10.1038\/S41598-021-01623-6","DOI":"10.1038\/s41598-021-01623-6"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Matano F, Murai Y, Watanabe A, et al. Case report: a case of moyamoya syndrome associated with multiple endocrine neoplasia type 2A. Front Endocrinol (Lausanne). 2021;12:703410. doi: 10.3389\/FENDO.2021.703410","DOI":"10.3389\/fendo.2021.703410"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Noda K, Hattori Y, Hori M, et al. Amplified risk of intracranial artery stenosis\/occlusion associated with RNF213 p.R4810K in familial hypercholesterolemia. JACC Asia. 2023;3 (4):625-33. doi: 10.1016\/J.JACASI.2023.03.011","DOI":"10.1016\/j.jacasi.2023.03.011"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Koyama S, Ito K, Terao C, et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. Nat Genet. 2020;52 (11):1169-77. doi: 10.1038\/S41588-020-0705-3","DOI":"10.1038\/s41588-020-0705-3"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Ozaki D, Endo H, Tashiro R, et al. Association between RNF213 c.14576G&gt;A variant (rs112735431) and peripheral pulmonary artery stenosis in moyamoya disease. Cerebrovasc Dis. 2022;51 (3):282-7. doi: 10.1159\/000519717","DOI":"10.1159\/000519717"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Chang SA, Song JS, Park TK, et al. Nonsyndromic peripheral pulmonary artery stenosis is associated with homozygosity of RNF213 p.Arg4810Lys regardless of co-occurrence of moyamoya disease. Chest. 2018;153 (2):404-13. doi: 10.1016\/J.CHEST.2017.09.023","DOI":"10.1016\/j.chest.2017.09.023"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Suzuki H, Kataoka M, Hiraide T, et al. Genomic comparison with supercentenarians identifies RNF213 as a risk gene for pulmonary arterial hypertension. Circ Genomic Precis Med. 2018;11 (12):e002317. doi: 10.1161\/CIRCGEN.118.002317","DOI":"10.1161\/CIRCGEN.118.002317"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Hara S, Mukawa M, Akagawa H, et al. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients. J Neurosurg Pediatr. 2021;29 (1):48-56. doi: 10.3171\/2021.7.PEDS21250","DOI":"10.3171\/2021.7.PEDS21250"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Bang OY, Chung JW, Kim DH, et al. Moyamoya disease and spectrums of RNF213 vasculopathy. Transl Stroke Res. 2020;11 (4):580-9. doi: 10.1007\/s12975-019-00743-6","DOI":"10.1007\/s12975-019-00743-6"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28 (11):939-50. doi: 10.1016\/j.molmed.2022.08.009","DOI":"10.1016\/j.molmed.2022.08.009"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Zhou S, Ambalavanan A, Rochefort D, et al. RNF213 is associated with intracranial aneurysms in the French-Canadian population. Am J Hum Genet. 2016;99 (5):1072-85. doi: 10.1016\/j.ajhg.2016.09.001","DOI":"10.1016\/j.ajhg.2016.09.001"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Ihara M, Yamamoto Y, Hattori Y, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21 (8):747-58. doi: 10.1016\/S1474-4422(22)00165-X","DOI":"10.1016\/S1474-4422(22)00165-X"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Yoshimoto T, Ishiyama H, Hattori Y, et al. Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke\/transient ischemic attack. Atherosclerosis. 2023;382:117281. doi: 10.1016\/j.atherosclerosis.2023.117281","DOI":"10.1016\/j.atherosclerosis.2023.117281"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y; Research Committee on Moyamoya Disease in Japan. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007;38 (5):1430-5. doi: 10.1161\/STROKEAHA.106.478297","DOI":"10.1161\/STROKEAHA.106.478297"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Kuroda S, Kashiwazaki D, Akioka N, et al. Specific shrinkage of carotid forks in moyamoya disease: a novel key finding for diagnosis. Neurol Med Chir (Tokyo). 2015;55 (10):796-804. doi: 10.2176\/nmc.oa.2015-0044","DOI":"10.2176\/nmc.oa.2015-0044"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Kobayashi H, Matsuda Y, Hitomi T, et al. Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in vitro and in vivo. J Am Heart Assoc. 2015;4 (7):e002146. doi: 10.1161\/JAHA.115.002146","DOI":"10.1161\/JAHA.115.002146"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Morito D, Nishikawa K, Hoseki J, et al. Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep. 2014;4:4442. doi: 10.1038\/srep04442","DOI":"10.1038\/srep04442"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Kotani Y, Morito D, Yamazaki S, et al. Neuromuscular regulation in zebrafish by a large AAA+ ATPase\/ubiquitin ligase, mysterin\/RNF213. Sci Rep. 2015;5:16161. doi: 10.1038\/srep16161","DOI":"10.1038\/srep16161"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Sugihara M, Morito D, Ainuki S, et al. The AAA+ ATPase\/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets. J Cell Biol. 2019;218 (3):949-60. doi: 10.1083\/jcb.201712120","DOI":"10.1083\/jcb.201712120"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Zhao J, Qiu C, Zhang G, Chen L, He S, Ma J. LncRNA-mRNA co-expression profiles relative to vascular remodeling in moyamoya patients without RNF213 mutation. World Neurosurg. 2022;158:e880-8. doi: 10.1016\/j.wneu.2021.11.104","DOI":"10.1016\/j.wneu.2021.11.104"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Ohkubo K, Sakai Y, Inoue H, et al. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells. Sci Rep. 2015;5:13191. doi: 10.1038\/srep13191","DOI":"10.1038\/srep13191"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Ishigami D, Miyawaki S, Imai H, et al. RNF213 p.Arg4810Lys heterozygosity in moyamoya disease indicates early onset and bilateral cerebrovascular events. Transl Stroke Res. 2022;13 (3):410-9. doi: 10.1007\/s12975-021-00956-8","DOI":"10.1007\/s12975-021-00956-8"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Torazawa S, Miyawaki S, Imai H, et al. RNF213 p.Arg4810Lys wild type is associated with de novo hemorrhage in asymptomatic hemispheres with moyamoya disease. Transl Stroke Res. 2023. doi: 10.1007\/s12975-023-01159-z","DOI":"10.1007\/s12975-023-01159-z"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Wang C, Kong D, Song H, Liu J, Qi M, Li L. Characterization of global research trends and prospects on moyamoya disease: bibliometric analysis. World Neurosurg. 2023;173:e329-40. doi: 10.1016\/j.wneu.2023.02.047","DOI":"10.1016\/j.wneu.2023.02.047"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Uemura M, Kanazawa M, Yamagishi T, et al. Role of RNF213 p.4810K variant in the development of intracranial arterial disease in patients treated with nilotinib. J Neurol Sci. 2020;408:116577. doi: 10.1016\/j.jns.2019.116577","DOI":"10.1016\/j.jns.2019.116577"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Kamimura T, Okazaki S, Morimoto T, et al. Prevalence of RNF213 p.R4810K variant in early-onset stroke with intracranial arterial stenosis. Stroke. 2019;50 (6):1561-3. doi: 10.1161\/STROKEAHA.118.024712","DOI":"10.1161\/STROKEAHA.118.024712"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Hongo H, Miyawaki S, Imai H, et al. Smaller outer diameter of atherosclerotic middle cerebral artery associated with RNF213 c.14576G&gt;A variant (rs112735431). Surg Neurol Int. 2017;8:104. doi: 10.4103\/SNI.SNI_59_17","DOI":"10.4103\/sni.sni_59_17"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Kim JS, Lee HB, Kwon HS. RNF213 polymorphism in intracranial artery dissection. J stroke. 2018;20 (3):404-6. doi: 10.5853\/JOS.2018.02075","DOI":"10.5853\/jos.2018.02075"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7 (11):1056-66. doi: 10.1016\/S1474-4422(08)70240-0","DOI":"10.1016\/S1474-4422(08)70240-0"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Fukushima H, Takenouchi T, Kosaki K. Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy. Am J Med Genet A. 2016;170 (9):2453-6. doi: 10.1002\/ajmg.a.37829","DOI":"10.1002\/ajmg.a.37829"},{"key":"52","doi-asserted-by":"publisher","unstructured":"52. Hiraide T, Kataoka M, Suzuki H, et al. Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension. J Heart Lung Transplant. 2020;39 (2):103-12. doi: 10.1016\/J.HEALUN.2019.08.022","DOI":"10.1016\/j.healun.2019.08.022"},{"key":"53","doi-asserted-by":"publisher","unstructured":"53. Komiyama M. RNF213 genetic variant and the arterial circle of willis. J Stroke Cerebrovasc Dis. 2018;27 (10):2892-3. doi: 10.1016\/j.jstrokecerebrovasdis.2018.07.010","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.010"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/2\/91_JNMS.2024_91-215\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T04:06:22Z","timestamp":1716609982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/2\/91_JNMS.2024_91-215\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2024_91-215","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"article-number":"JNMS.2024_91-215"}}